Literature DB >> 31892779

VA Ketamine Controversies.

Eugene Raggi1, Srikantha L Rao1.   

Abstract

Entities:  

Year:  2019        PMID： 31892779      PMCID： PMC6913615     

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


× No keyword cloud information.
  6 in total

1.  Ketamine for chronic depression: two cautionary tales

Authors:  Jeanne Talbot; Jennifer L. Phillips; Pierre Blier
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

2.  The VA Ketamine Controversies.

Authors:  Cynthia M A Geppert
Journal:  Fed Pract       Date:  2019-10

3.  Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Vwaire Orhurhu; Mariam Salisu Orhurhu; Anuj Bhatia; Steven P Cohen
Journal:  Anesth Analg       Date:  2019-07       Impact factor: 5.108

Review 4.  Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?

Authors:  Chittaranjan Andrade
Journal:  J Clin Psychiatry       Date:  2017-07       Impact factor: 4.384

Review 5.  A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.

Authors:  Gerard Sanacora; Mark A Frye; William McDonald; Sanjay J Mathew; Mason S Turner; Alan F Schatzberg; Paul Summergrad; Charles B Nemeroff
Journal:  JAMA Psychiatry       Date:  2017-04-01       Impact factor: 21.596

Review 6.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.